Delivery Order SPE2DB22D1106-SPE2DB25FEGZ9

Award Date 4/9/25
Potential Completion Date 4/30/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.74, is a Firm Fixed Price Delivery Order for the supply of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product. The contract has a completion date of February 6, 2025 and was awarded on January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of IMBRUVICA 140 MG CAPSULE 90S. The $8,116.87 firm fixed-price contract has a completion date of December 23, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULES. It is a Firm Fixed Price Delivery Order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used for various medical treatments. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a brand-name pharmaceutical product. The contract has a firm fixed price of $8,116.87 and a period of performance ending on July 24, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication, at a firm fixed price of $16,233.74. The contract has an ultimate completion date of May 19, 2025 and was awarded on April 28, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 firm fixed-price delivery order is for the provision of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication. The contract has a completion date of February 20, 2025 and was awarded on January 29, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $8,116.87 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product, with a performance period ending on June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,845.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract provides for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication, to support military...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGZ9
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 140 MG CAPSULE 90S. The contract has a firm fixed price of $16,233.74 and a period of performance through April 30, 2025.

The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award supports the DLA's mission of providing medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 7/9/25, 9:45 AM